Logo wahanariau.com
  2. New jersey

New jersey

Index
Globenewswire

Teva to Present at the Goldman Sachs Global Healthcare Conference

Selasa, 02 Juni 2026 - 19:10:43 Wib
Globenewswire

Verisk Redefines U.S. Hurricane Risk Modeling with Reengineered Tropical Cyclone Model, Delivered on Its New Synergy Studio Platform

Selasa, 02 Juni 2026 - 19:04:01 Wib
Globenewswire

Leading Philippine Telecom Provider Selects Synchronoss to Deliver Personal Cloud Solutions to 54 Million Customers

Selasa, 26 Mei 2026 - 22:04:11 Wib
Globenewswire

Verisk Welcomes Pradip Patiath to its Board of Directors

Rabu, 20 Mei 2026 - 21:38:09 Wib
Globenewswire

IMA Introduces Micro-credentials to Help Finance Professionals Build Practical, Future-Ready Skills

Selasa, 19 Mei 2026 - 21:24:01 Wib
Globenewswire

Teva Study Finds Only 23% of Younger Adults with Mood Disorders and Tardive Dyskinesia (TD) Symptoms Are Formally Diagnosed with TD Despite Widespread Impact

Senin, 18 Mei 2026 - 21:03:29 Wib
Globenewswire

Kanghong Pharmaceutical and Vanotech Announce Positive Phase 2b Results for KH607 in Major Depressive Disorder

Jumat, 15 Mei 2026 - 22:02:42 Wib
Globenewswire

Chengdu Origen and Vanotech Announce KHN921 Investigational New Drug application clearance by the US FDA for the treatment of hypertrophic cardiomyopathy (HCM) associated with MYBPC3 mutations

Kamis, 14 Mei 2026 - 20:53:36 Wib
Globenewswire

Verisk Brings Its Trusted Analytics and Generative AI Capabilities Directly into Anthropic’s Claude

Selasa, 05 Mei 2026 - 22:49:07 Wib
Globenewswire

Teva to Present at the BofA Securities Health Care Conference

Selasa, 05 Mei 2026 - 22:17:45 Wib
Globenewswire

Teva to Acquire Emalex Biosciences, Adding NDA-Ready, First-in-Class Therapy to Neuroscience Pipeline and Accelerating Teva’s Pivot to Growth Strategy

Rabu, 29 April 2026 - 23:06:45 Wib
Globenewswire

Teva Launches Home Ground™ Schizophrenia Community, a New Online Resource Hub for People Living with Schizophrenia and Their Care Partners

Rabu, 15 April 2026 - 21:53:02 Wib
Globenewswire

BHAV Acquisition Corp Announces Separate Trading of its Class A Ordinary Shares and Rights, Commencing April 16, 2026

Selasa, 14 April 2026 - 21:06:15 Wib
Globenewswire

Teva Gains Biosimilar Momentum with U.S. FDA Approval of PONLIMSI™ (denosumab-adet) and Dual Filing Acceptance for Biosimilar Candidate to Xolair® (omalizumab)

Senin, 30 Maret 2026 - 22:26:49 Wib
Globenewswire

BHAV Acquisition Corp Announces Closing of $100 Million Initial Public Offering

Senin, 23 Maret 2026 - 04:23:31 Wib
Globenewswire

BHAV Acquisition Corp Announces Pricing of $100 Million Initial Public Offering

Jumat, 20 Maret 2026 - 04:16:25 Wib
Globenewswire

Checkmarx Redefines Application Security for the Age of Agentic Development

Selasa, 17 Maret 2026 - 04:38:11 Wib
Globenewswire

Jelly Toast Diluncurkan di India untuk Memudahkan Perayaan Sehari-hari

Rabu, 04 Maret 2026 - 23:12:24 Wib
Globenewswire

Teva and Blackstone Life Sciences Announce $400 Million Strategic Growth Capital Agreement to Advance duvakitug

Rabu, 04 Maret 2026 - 05:40:38 Wib
Globenewswire

Jelly Toast Launches in India to Simplify Everyday Celebrations

Rabu, 04 Maret 2026 - 05:25:49 Wib
Globenewswire

Telkomsel Memperluas Implementasi Capsyl Cloud bersama Synchronoss

Rabu, 04 Maret 2026 - 05:17:32 Wib
Globenewswire

Telkomsel Expands Capsyl Cloud Deployment with Synchronoss

Selasa, 03 Maret 2026 - 05:04:03 Wib
Globenewswire

Teva to Present at the Upcoming Investor Conferences in March

Rabu, 25 Februari 2026 - 06:28:43 Wib
Globenewswire

U.S. Food and Drug Administration (FDA) Accepts Teva’s New Drug Application (NDA) for Olanzapine Extended-Release Injectable Suspension (TEV-'749) for the Once-Monthly Treatment of Schizophrenia in Adults

Senin, 23 Februari 2026 - 11:54:59 Wib
Globenewswire

Teva and Sanofi’s duvakitug phase 2b maintenance data demonstrated clinically meaningful durable efficacy in ulcerative colitis and Crohn’s disease

Kamis, 19 Februari 2026 - 20:10:05 Wib